Oragenics, Inc.

8-K Entered a material agreement; Director or officer change; Shareholder vote results Jul 6, 2026 8-K Regulation FD disclosure; Other events May 19, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Other events May 7, 2026 8-K Other events Apr 13, 2026 8-K Item 5.08 Mar 31, 2026 10-K Fiscal year ended 2025-12-31 Mar 16, 2026 8-K Other events Mar 11, 2026 8-K Entered a material agreement Jan 22, 2026 8-K Regulation FD disclosure Jan 20, 2026 8-K Director or officer change Dec 15, 2025 8-K Other events Nov 12, 2025 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Entered a material agreement; Delisting notice or listing-rule failure; Regulation FD disclosure Oct 21, 2025 8-K Director or officer change Sep 2, 2025 8-K Other events Aug 11, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws; Other events Jul 2, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Other events May 28, 2025 8-K Regulation FD disclosure May 20, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Entered a material agreement; Director or officer change; Shareholder vote results May 2, 2025 8-K Other events Apr 9, 2025 8-K Other events Mar 27, 2025 10-K Fiscal year ended 2024-12-31 Mar 14, 2025 8-K Other events Mar 6, 2025 8-K Item 5.08 Feb 18, 2025 8-K Other events Feb 5, 2025 8-K Other events Jan 21, 2025 8-K Entered a material agreement; Director or officer change; Other events Jan 17, 2025 8-K Director or officer change; Shareholder vote results; Other events Dec 16, 2024 8-K Terminated a material agreement Nov 29, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Regulation FD disclosure Oct 18, 2024 8-K Regulation FD disclosure Oct 16, 2024 8-K Entered a material agreement Oct 15, 2024 8-K Other events Oct 9, 2024 8-K Director or officer change; Item 5.08 Sep 20, 2024 8-K Entered a material agreement; Other events Sep 5, 2024 8-K Other events Aug 21, 2024